Amneal Pharmaceuticals, Inc (AMRX) insider trading
Every open-market stock purchase and sale by Amneal Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Jason B. Daly (C-suite exec) and 2 others sold $7.2M in the last 90 days.
- Last insider buy: Gautam Patel (Director), $211K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $9.8M (6 sales). Last close $20.20 on Oct 21, 2026.
Recent AMRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 17, 2026 | J Kevin Buchi (Director) | Sold (not open market) | — |
| Sep 11, 2026 | J Kevin Buchi (Director) | Bought (not open market) | $295K |
| Sep 11, 2026 | J Kevin Buchi (Director) | Bought (not open market) | — |
| Sep 1, 2026 | Andrew S Boyer (President) | Sold (not open market) | — |
| Aug 21, 2026 | Andrew S Boyer (President) | Sold (not open market) | — |
| Aug 13, 2026 | John Kiely (Director) | Sold | $882K |
| Aug 13, 2026 | John Kiely (Director) | Sold (not open market) | — |
| Aug 12, 2026 | Jason B. Daly (C-suite exec) | Sold | $3.7M |
| Aug 12, 2026 | Nikita Shah (President) | Sold | $2.6M |
| Aug 11, 2026 | J Kevin Buchi (Director) | Sold (not open market) | $2.9M |
| Aug 11, 2026 | Jason B. Daly (C-suite exec) | Sold | $117K |
| Aug 10, 2026 | Tushar Bhikhubhai Patel (Insider) | Bought (not open market) | — |
| Aug 10, 2026 | Chintu Patel (CEO) | Bought (not open market) | — |
| Aug 10, 2026 | Gautam Patel (Director) | Bought (not open market) | — |
| Aug 10, 2026 | Chirag K. Patel (CEO) | Bought (not open market) | — |
| May 11, 2026 | Deborah M. Autor (Director) | Sold | $451K |
| May 7, 2026 | Shlomo Yanai (Director) | Bought (not open market) | — |
| May 7, 2026 | Deborah M. Autor (Director) | Bought (not open market) | — |
| May 7, 2026 | J Kevin Buchi (Director) | Bought (not open market) | — |
| May 7, 2026 | Jeffrey P. George (Director) | Bought (not open market) | — |
| May 7, 2026 | John Kiely (Director) | Bought (not open market) | — |
| May 7, 2026 | Paul M Meister (Director) | Bought (not open market) | — |
| May 7, 2026 | Ted C Nark (Director) | Bought (not open market) | — |
| May 7, 2026 | Gautam Patel (Director) | Bought (not open market) | — |
| May 6, 2026 | Shlomo Yanai (Director) | Bought (not open market) | — |
Who's trading AMRX
- J Kevin Buchi, Director: other filings, last Sep 17, 2026
- Andrew S Boyer, President: other filings, last Sep 1, 2026
- John Kiely, Director: sold $882K (1 sale), last Aug 13, 2026
- Nikita Shah, President: sold $4.1M (2 sales), last Aug 12, 2026
- Jason B. Daly, C-suite exec: sold $3.8M (2 sales), last Aug 12, 2026
- Chintu Patel, CEO: other filings, last Aug 10, 2026
- Chirag K. Patel, CEO: other filings, last Aug 10, 2026
- Tushar Bhikhubhai Patel, Insider: other filings, last Aug 10, 2026
- Gautam Patel, Director: other filings, last Aug 10, 2026
- Deborah M. Autor, Director: sold $451K (1 sale), last May 11, 2026
- Shlomo Yanai, Director: other filings, last May 7, 2026
- Jeffrey P. George, Director: other filings, last May 7, 2026
- Paul M Meister, Director: other filings, last May 7, 2026
- Ted C Nark, Director: sold $586K (1 sale), last May 7, 2026
- Tasos Konidaris, CFO: other filings, last Mar 4, 2026
Get free alerts when an insider at Amneal Pharmaceuticals, Inc files a new trade →